FDA Approves New Drug for Metastatic Breast Cancer

#pharmadigest #GPATpreparation #newdrugapprovals #NIPER
✔FDA Approves New Drug for Metastatic Breast Cancer 📖 📖
The U.S. Food and Drug Administration (FDA) approved Pfizer’s PARP inhibitor, Talzenna (talazoparib), for patients with a germline BRCA-mutated (gBRCAm), HER2-negative breast cancer..
👉 In this video, we will learn about newly approved Drug for Metastatic Breast Cancer by FDA. 👈
===============================================================================
Please subscribe the channel “Pharma Digest” 🙏
Please like and share video ✔✔✔
================================================================================
Music: www.bensound.com
I am declared here by way of declaring that all Images use to make this video is from Google Search www.google.com. Google Advanced Search is used to find all images, usage rights: free to use, share or modify. Some images are created by the youtube Creator.
Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research.

[@devisree4589]

Thank you sir.
This is very useful to me.